Company
Scancell Holdings plc
Headquarters: Oxford, United Kingdom
Employees: 25
CEO: Prof. Lindy Gillian Durrant Ph.D.
Market Cap
£103.1 Million
GBP as of Jan. 1, 2025
US$129.4 Million
Scancell Holdings plc Categories
United Kingdom Healthcare BiotechnologyUnited Kingdom Healthcare United Kingdom Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $113.24 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $76.33 B |
| Marinomed Biotech AG | $56.13 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. The company's product candidates include SCIB1, which is in phase II clinical trial for the treatment of metastatic melanoma; SCIB2 for the treatment of non-small cell lung cancer; and Modi-1 that is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers. It also develops Modi-2, which targets homocitrullinated cancer antigens. In addition, the company develops SCOV1 and SCOV2 COVIDITY, a prophylactic DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Oct. 31, 2023 |
| Revenue TTM | £5.3 M |
| EBITDA | £-17,515,000 |
| Gross Profit TTM | £4.7 M |
| Profit Margin | 90.04% |
| Operating Margin | -248.32% |
| Quarterly Revenue Growth | % |
Stocks & Indices
Scancell Holdings plc has the following listings and related stock indices.
Stock: LSE: SCLP wb_incandescent
Stock: FSX: SCP wb_incandescent
Stock: OTC: SCNLF wb_incandescent